SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Walter Morton who wrote (2305)6/9/1999 8:52:00 PM
From: Walter Morton  Respond to of 2742
 
"...Biotech has conducted a preliminary safety study using PAI-2 to treat leg ulcers and has initiated a 120 patient clinical trial on patients with leg ulcers. This trial is being co-funded by the Australian government." emedtrade.com

bioaust.com.au



To: Walter Morton who wrote (2305)6/10/1999 1:25:00 AM
From: Walter Morton  Read Replies (2) | Respond to of 2742
 
Why wouldn't PMS&V be interested in CIST?

If CIST's technology was good enought to allegedly steal isn't it good enough for IMNX to buy?